Graham McClorey

2.4k total citations
41 papers, 1.8k citations indexed

About

Graham McClorey is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Graham McClorey has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 7 papers in Genetics. Recurrent topics in Graham McClorey's work include Muscle Physiology and Disorders (28 papers), RNA Interference and Gene Delivery (19 papers) and RNA Research and Splicing (14 papers). Graham McClorey is often cited by papers focused on Muscle Physiology and Disorders (28 papers), RNA Interference and Gene Delivery (19 papers) and RNA Research and Splicing (14 papers). Graham McClorey collaborates with scholars based in United Kingdom, United States and Sweden. Graham McClorey's co-authors include Matthew J. A. Wood, Steve D. Wilton, Sue Fletcher, Subhashis Banerjee, Michael J. Gait, Caroline Godfrey, Hong M. Moulton, Patrick L. Iversen, Thomas C. Roberts and Corinne Betts and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Nano Letters.

In The Last Decade

Graham McClorey

40 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Graham McClorey United Kingdom 24 1.7k 353 243 204 190 41 1.8k
Caroline Godfrey United Kingdom 16 1.5k 0.9× 192 0.5× 209 0.9× 162 0.8× 164 0.9× 24 1.6k
Amer F. Saleh United Kingdom 18 1.4k 0.8× 187 0.5× 237 1.0× 119 0.6× 196 1.0× 30 1.5k
Giuliano Giuseppe Stirparo United Kingdom 21 1.8k 1.0× 179 0.5× 106 0.4× 226 1.1× 254 1.3× 29 2.1k
Maqsood A. Wani United States 18 1.1k 0.7× 265 0.8× 189 0.8× 93 0.5× 134 0.7× 22 1.6k
Takako Yoshida‐Moriguchi United States 14 1.6k 0.9× 239 0.7× 84 0.3× 130 0.6× 124 0.7× 16 1.9k
Hollie A. Harper United States 7 895 0.5× 422 1.2× 63 0.3× 186 0.9× 92 0.5× 10 1.0k
Suzan M. Hammond United Kingdom 17 1.2k 0.7× 207 0.6× 385 1.6× 107 0.5× 53 0.3× 32 1.4k
Joel R. Chamberlain United States 15 1.4k 0.8× 562 1.6× 187 0.8× 152 0.7× 30 0.2× 23 1.6k
Stéphanie Lorain France 18 1.6k 1.0× 366 1.0× 126 0.5× 200 1.0× 98 0.5× 32 1.9k
Xavier M. Anguela United States 17 1.7k 1.0× 1.3k 3.7× 101 0.4× 182 0.9× 53 0.3× 31 2.2k

Countries citing papers authored by Graham McClorey

Since Specialization
Citations

This map shows the geographic impact of Graham McClorey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham McClorey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham McClorey more than expected).

Fields of papers citing papers by Graham McClorey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham McClorey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham McClorey. The network helps show where Graham McClorey may publish in the future.

Co-authorship network of co-authors of Graham McClorey

This figure shows the co-authorship network connecting the top 25 collaborators of Graham McClorey. A scholar is included among the top collaborators of Graham McClorey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham McClorey. Graham McClorey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baker, Ysobel R., Graham McClorey, Matthew J. A. Wood, et al.. (2022). Covalently attached intercalators restore duplex stability and splice-switching activity to triazole-modified oligonucleotides. RSC Chemical Biology. 3(6). 765–772. 3 indexed citations
2.
Baker, Ysobel R., Jinfeng Chen, Pawan Kumar, et al.. (2022). An LNA-amide modification that enhances the cell uptake and activity of phosphorothioate exon-skipping oligonucleotides. Nature Communications. 13(1). 4036–4036. 27 indexed citations
3.
Oieni, Jacopo, Joanna Zemła, Małgorzata Lekka, et al.. (2022). Exon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical properties. Molecular Therapy — Nucleic Acids. 29. 955–968. 8 indexed citations
4.
Mamchaoui, Kamel, M.K. Tsoumpra, Rika Maruyama, et al.. (2021). Immortalized Canine Dystrophic Myoblast Cell Lines for Development of Peptide-Conjugated Splice-Switching Oligonucleotides. Nucleic Acid Therapeutics. 31(2). 172–181. 10 indexed citations
5.
Aoki, Yoshitsugu, Taavi Lehto, Shouta Miyatake, et al.. (2021). Fine Tuning of Phosphorothioate Inclusion in 2′-O-Methyl Oligonucleotides Contributes to Specific Cell Targeting for Splice-Switching Modulation. Frontiers in Physiology. 12. 689179–689179.
6.
Gait, Michael J., Andrey Arzumanov, Graham McClorey, et al.. (2018). Cell-Penetrating Peptide Conjugates of Steric Blocking Oligonucleotides as Therapeutics for Neuromuscular Diseases from a Historical Perspective to Current Prospects of Treatment. Nucleic Acid Therapeutics. 29(1). 1–12. 65 indexed citations
7.
Blain, A., Elizabeth Greally, Graham McClorey, et al.. (2018). Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy. PLoS ONE. 13(6). e0198897–e0198897. 18 indexed citations
8.
Peccate, Cécile, Laura Julien, Graham McClorey, et al.. (2016). Antisense pre-treatment increases gene therapy efficacy in dystrophic muscles. Human Molecular Genetics. 25(16). 3555–3563. 29 indexed citations
9.
Betts, Corinne, Amer F. Saleh, Carolyn A. Carr, et al.. (2015). Implications for Cardiac Function Following Rescue of the Dystrophic Diaphragm in a Mouse Model of Duchenne Muscular Dystrophy. Scientific Reports. 5(1). 11632–11632. 10 indexed citations
10.
Järver, Peter, Eman M. Zaghloul, Andrey Arzumanov, et al.. (2015). Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oligonucleotides. Nucleic Acid Therapeutics. 25(2). 65–77. 17 indexed citations
11.
Roberts, Thomas C., Henrik J. Johansson, Graham McClorey, et al.. (2015). Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration. Human Molecular Genetics. 24(23). 6756–6768. 38 indexed citations
12.
Hammond, Suzan M., Graham McClorey, Joel Z. Nordin, et al.. (2014). Correlating In Vitro Splice Switching Activity With Systemic In Vivo Delivery Using Novel ZEN-modified Oligonucleotides. Molecular Therapy — Nucleic Acids. 3. e212–e212. 9 indexed citations
13.
Shabanpoor, Fazel, Graham McClorey, Amer F. Saleh, et al.. (2014). Bi-specific splice-switching PMO oligonucleotides conjugated via a single peptide active in a mouse model of Duchenne muscular dystrophy. Nucleic Acids Research. 43(1). 29–39. 26 indexed citations
14.
Roberts, Thomas C., Caroline Godfrey, Graham McClorey, et al.. (2013). Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover. Nucleic Acids Research. 41(20). 9500–9513. 79 indexed citations
15.
Roberts, Thomas C., K. Emelie M. Blomberg, Graham McClorey, et al.. (2012). Expression Analysis in Multiple Muscle Groups and Serum Reveals Complexity in the MicroRNA Transcriptome of the mdx Mouse with Implications for Therapy. Molecular Therapy — Nucleic Acids. 1. e39–e39. 118 indexed citations
16.
McClorey, Graham, et al.. (2011). Antisense oligonucleotide corrects splice abnormality in hereditary myopathy with lactic acidosis. Gene. 494(2). 231–236. 10 indexed citations
17.
Adams, A.M., Graham McClorey, Hong M. Moulton, et al.. (2007). Induced dystrophin exon skipping in human muscle explants. The Journal of Gene Medicine. 9(6). 534–535. 7 indexed citations
18.
Wilton, Steve D., et al.. (2007). Antisense Oligonucleotide-induced Exon Skipping Across the Human Dystrophin Gene Transcript. Molecular Therapy. 15(7). 1288–1296. 128 indexed citations
19.
Wood, Matthew J. A., HaiFang Yin, & Graham McClorey. (2007). Modulating the Expression of Disease Genes with RNA-Based Therapy. PLoS Genetics. 3(6). e109–e109. 77 indexed citations
20.
McClorey, Graham, Sue Fletcher, & Steve D. Wilton. (2005). Splicing intervention for Duchenne muscular dystrophy. Current Opinion in Pharmacology. 5(5). 529–534. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Godfrey Breakdown of academic impact, for papers by Amer F. Saleh Breakdown of academic impact, for papers by Giuliano Giuseppe Stirparo Breakdown of academic impact, for papers by Maqsood A. Wani Breakdown of academic impact, for papers by Takako Yoshida‐Moriguchi Breakdown of academic impact, for papers by Hollie A. Harper Breakdown of academic impact, for papers by Suzan M. Hammond Breakdown of academic impact, for papers by Joel R. Chamberlain Breakdown of academic impact, for papers by Stéphanie Lorain Breakdown of academic impact, for papers by Xavier M. Anguela
Rankless by CCL
2026